Vitamin D treatment distinctly modulates cytokine production by peripheral blood mononuclear cells among patients with chronic cardiac and indeterminate clinical forms of Chagas disease
Authors:
- Kamila Kássia dos Santos OliveiraKOKamila Kássia dos Santos Oliveira
- Diego José Lira TorresDTDiego José Lira Torres
- Michelle da Silva BarrosMBMichelle da Silva Barros
- Leyllane Rafael MoreiraLMLeyllane Rafael Moreira
- Claudeir Dias da Silva JuniorCJClaudeir Dias da Silva Junior
- Ana Karine de Araújo SoaresASAna Karine de Araújo Soares
- Maria da Glória Aureliano Melo CavalcanteMCMaria da Glória Aureliano Melo Cavalcante
- Wilson Alves de Oliveira JuniorWJWilson Alves de Oliveira Junior
- Michelle Christiane da Silva RabelloMRMichelle Christiane da Silva Rabello
- Virginia Maria Barros de LorenaVLVirginia Maria Barros de Lorena
Open Access
- 13 September 2024
- journal article
- research article
- Published by Wiley in Immunity, Inflammation and Disease
- Vol. 12 (9) , e1330
Abstract
Introduction: Chagas disease is caused by the protozoan Trypanosoma cruzi and is clinically divided into acute and chronic phases. Chronic Chagas cardiomyopathy is the most studied manifestation of the disease. Vitamin D deficiency has been suggested as a risk factor for cardiovascular disease. No studies demonstrate the action of this hormone in the cells of patients with chronic Chagas heart disease.Objective: To evaluate the in vitro immunomodulatory effect of vitamin D on peripheral blood mononuclear cells of patients with the different chronic clinical forms of Chagas disease. Evaluating vitamin D's in vitro effect on blood cells by producing cytokines.Methods: Thirteen patients of the undetermined form (IND), 13 of the mild cardiac form (CARD1) and 14 of the severe cardiac form (CARD2) of Chagas disease, and 12 with idiopathic heart disease (CARDid) were included. The cells obtained from peripheral blood were treated in vitro with vitamin D (1 × 10−7 M) for 24 h and cytokines were dosed in the culture supernatant.Results: Although it was not possible to demonstrate statistically significant differences between the groups studied, our data showed that the cells treated with vitamin D modify (p < .05) the production of interferon‐γ (IFN‐γ) (decrease in IND), tumor necrosis factor‐α (TNF‐α) (decreased in CARD1 and CARDid), interleukin (IL)‐6 (increased in all groups), and IL‐10 (decreased in CARD1, CARD2, and CARDid) when compared to untreated cells.Conclusion: In vitro treatment with vitamin D distinctly modulated the production of cytokines by mononuclear cells of peripheral blood among patients with chronic and indeterminate cardiac clinical forms of Chagas disease.Keywords
This publication has 61 references indexed in Scilit:
- Vitamin D and autoimmunity: new aetiological and therapeutic considerationsAnnals of the Rheumatic Diseases, 2007
- Modulatory Effects of 1,25-Dihydroxyvitamin D3 on Human B Cell DifferentiationThe Journal of Immunology, 2007
- Characterization of heart size and blood pressure in the vitamin D receptor knockout mouseThe Journal of Steroid Biochemistry and Molecular Biology, 2007
- Epidemic influenza and vitamin DEpidemiology and Infection, 2006
- Phenotypic and functional characteristics of CD28+ and CD28− cells from chagasic patients: distinct repertoire and cytokine expressionClinical and Experimental Immunology, 2004
- Evidence that Development of Severe Cardiomyopathy in Human Chagas' Disease Is Due to a Th1-Specific Immune ResponseInfection and Immunity, 2003
- Vitamin D: its role and uses in immunology 1The FASEB Journal, 2001
- Vitamin D3 and Its Synthetic Analogs Inhibit the Spontaneous in Vitro Immunoglobulin Production by SLE-Derived PBMCClinical Immunology, 2001
- The role of the immune response on the development of severe clinical forms of human Chagas diseaseMemórias do Instituto Oswaldo Cruz, 1999
- IFN-g in human Chagas' disease: protection or pathology?Brazilian Journal of Medical and Biological Research, 1998